John Joseph Strouse
@dukesickle
Followers
1K
Following
31
Statuses
604
Adult and pediatric hematologist, sickle cell provider and advocate
Duke University
Joined December 2017
RT @DrSusieC2: Don’t have a question This is more of a comment Have you read MY work? #ASH24 #ASHhaiku
0
1
0
RT @SCDFoundation: .@VertexPharma & @bluebirdbio are partnering with @CMSGov on the Cell & Gene Therapy Access Model starting in 2025. The…
0
3
0
RT @CaptainAV: A pie chart to assist all #ASH24 session moderators in moderating their sessions:
0
1
0
RT @CaptainAV: Cappellini MD, et al. ENERGIZE-T: A Global, Phase 3, Double-Blind, Randomized, Placebo-Controlled Study of Mitapivat in Adul…
0
9
0
Dr. Naomi Taylor discussing metabolism and solute carriers on erythroid differential at the ASH presidential symposium. Excellent! #ASH24
0
1
5
RT @Ruah_Mahmoud: With advancements like “double” editing and CD45-ADC conditioning regimens, we may soon reduce—or even eliminate—the need…
0
2
0
RT @CaptainAV: Mohammed A, et al. Evaluating High-Sensitivity Troponin Levels in Patients with Sickle Cell Disease Presenting to the Emerge…
0
3
0
RT @akshatdoctor: "From Pain to Progress" - my piece on status update of Gene editing at the Ernest Beutler prize ! Live now online - http…
0
5
0
RT @CaptainAV: Everyone wanted to do this study but Julia has the guts to do it! Congrats! Xu JZ, et al. A Phase 1b/2 Study of the Efficac…
0
6
0
RT @MySickleCare: Pfizer’s abrupt withdrawal of sickle cell drug Oxbryta called ‘tone deaf’ at ASH conference Experts said patients were d…
0
1
0
RT @RabiHannaMD: 👏👏 fantastic and important talk by Françoise Bernaudin @ASH_hematology #ASH24: long term outcomes in DREPAGREFFE study e…
0
3
0
Dr. Patrick Gallagher’s engaging presidential symposium presentation on RBC membranopathies #ASH24
0
2
6
David Nathan highlights role of HbF in treating SCD in his basic science Beutler award talk #ASH24 #SickleCellDisease
1
4
7
RT @MDJ_QISickleDoc: Melissa Creary was speaking my language at #ASH24... QI is a great approach to addressing health equity. https://t.co/…
0
2
0
Come to our later breaker educational session on the voxelotor withdrawal Monday 1030 AM SDCC Rm 33 #ASH24 #SickleCellDisease
0
0
3
RT @ninashah33: Happening now in room 25: symposium for mid career hematologists. Love being here with my frientor @mpdrc and doing the ind…
0
2
0
RT @RabiHannaMD: Congratulations 🎉and very well deserved recognition to Dr. Elaine Gluckman for receiving #ASH24 WALLACE H. COULTER AWARD -…
0
1
0
Dr. Payal Desai, SCAPN president, on access to curative/transformative therapy for SCD-multiple barriers! #ASH24 #SickleCellDisease
0
2
14